Sharon Wright, MD, MPH (Infectious Disease, BIDMC), spoke about the post-holiday surge and the importance of getting everyone vaccinated eventually to prevent the severe illness and complications of COVID-19, reduce hospitalizations and ultimately reduce deaths.

Dr. Sharon Wright with Beth Israel speaks about the latest hospital capacity and what the recent case increase could mean for emergency rooms.

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC), lead researcher on the Johnson & Johnson COVID-19 vaccine candidate, discussed the level of protection after receiving the first dose of a COVID-19 vaccination, how long people should still wear a mask, and a strategy shift to reach herd immunity.

What happens after the first COVID-19 dose?

The Baker administration, in partnership with the Massachusetts Life Sciences Center, announced four grants totaling $1.5 million to broaden coronavirus testing methods in the months ahead. BIDMC will be one of the hospitals analyzing existing coronavirus antigen tests.

State gives $1.5M in grants for development of new Covid testing

In the midst of the COVID-19 vaccines rollout, clinicians and researchers are working to assess next generation COVID-19 vaccine candidates, and as part of that effort, researchers are presenting alternatives to measure a vaccine’s effectiveness by using immune markers that a person develops in their blood after inoculation. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke to how trials so far suggest that levels of an antibody called immunoglobulin G (IgG) could serve as that proxy indicator.

As placebo-controlled testing falls out of favour, vaccine developers eye blood markers and challenge trials to assess next-generation candidates.

Nhi Vo (Radiology, BIDMC) looks over a carpet of daffodils left for medical workers at BIDMC by Boston-based floral company Cityscapes. Editor’s note: Photo is featured April 10.

The photos that helped us tell the stories of 2020

Good Morning America: Barouch’s lab studying new, more contagious COVID strains

American lab studying new, more contagious COVID-19...

The Boston Globe’s latest on what people need to know about the vaccine rollout in Massachusetts included Johnson & Johnson’s vaccine development in partnership with BIDMC. Johnson & Johnson expects to have early data from its trial by the end of January, with hopes of submitting an application for FDA emergency use authorization in February.

Five things you need to know about the vaccine rollout in Mass.

As 2021 begins, doctors from Massachusetts hospitals worry infections from holiday gatherings will crowd ICUs even more. David Longworth, MD (President, Lahey Hospital) expressed concern about the impact of the holidays in contributing a surge upon the existing surge.

Infectious Disease Doctors Look Back At A Tough Year — And Forward With Concern

Mary LaSalvia, MD (Infectious Disease, BIDMC) and Kenneth Wener, MD (Infectious Disease, LHMC) joined with other Boston infectious disease experts to address the COVID-19 pandemic and share 2021 resolutions in an opinion piece for the Boston Globe.

As we ring in a new year, here are our resolutions; please consider joining us.